-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on Bruker, Raises Price Target to $70

Benzinga·10/07/2026 13:38:32
Listen to the news
Barclays analyst Luke Sergott maintains Bruker (NASDAQ:BRKR) with a Overweight and raises the price target from $58 to $70.